Which component is directly reduced by aspirin that leads to decreased platelet aggregation?

Prepare for the EMT Pharmacology Test with a mix of challenging questions designed to mirror the exam format. Review key concepts, utilize questions with hints, and gain confidence to succeed on your test.

Multiple Choice

Which component is directly reduced by aspirin that leads to decreased platelet aggregation?

Explanation:
Aspirin decreases the ability of platelets to clump together by irreversibly inhibiting cyclooxygenase-1 in platelets, which blocks the production of thromboxane A2. Thromboxane A2 is a powerful promoter of platelet activation and aggregation and also causes vasoconstriction. Since platelets lack a nucleus, they can’t synthesize new COX-1, so the drop in thromboxane A2 persists until new platelets are formed. The other options don’t fit because they aren’t directly involved in the platelet aggregation pathway: hemoglobin synthesis is about red blood cells, dopamine release isn’t a key mediator of platelet function, and calcium deposition relates to bone and mineral metabolism.

Aspirin decreases the ability of platelets to clump together by irreversibly inhibiting cyclooxygenase-1 in platelets, which blocks the production of thromboxane A2. Thromboxane A2 is a powerful promoter of platelet activation and aggregation and also causes vasoconstriction. Since platelets lack a nucleus, they can’t synthesize new COX-1, so the drop in thromboxane A2 persists until new platelets are formed. The other options don’t fit because they aren’t directly involved in the platelet aggregation pathway: hemoglobin synthesis is about red blood cells, dopamine release isn’t a key mediator of platelet function, and calcium deposition relates to bone and mineral metabolism.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy